59 results about "Benzalkonium chloride" patented technology

The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide.

New liquid compositions are described for the relief of the xerostomia and the treatment of associated disorders, in which the compositions contain: a) saline saliva substitute agents selected from the group consisting of sodium chloride, potassium chloride, sodium bicarbonate, monobasic potassium phosphate, and dibasic phosphate potassium; b) saliva production stimulation agents selected from the group consisting of citric acid or its alkali metal salts and malic acid or its alkali metal salts; c) oral antiseptics selected from the group consisting of triclosan, chlorhexidine and its salts, benzalkonium and its salts, and cetylpyridinium chloride; d) anticariogenic agents selected from the group consisting of fluoride sodium, sodium monofluorophosphate, and xylitol; and e) oral mucosa protective agents selected from the group consisting of vitamin E acetate, panthenol, dipotassium glycyrrhizinate and extracts of aloe vera. The aforementioned compositions are presented in the form of mouthwashes, sprays, oral gels, and toothpastes.

The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasured single unit dose of albuterol for asthmatic patients 2 to 12 years of age. The present solution may be free of anti-microbial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 0.63 mg or about 1.25 mg albuterol.

A saline liquid for treating allergic rhinitis by using it to flush nasal cavity contain proportionally sodium chloride, mint oil, polyoxyvinyl sorbitan monooleate, benzalkonium bromide and distilled water.

The invention relates to a hydrojet having a bacteriostatic function and a deodorant function exclusively used for sanitary towel, which is a hydrojet product made by mixing benzalkonium chloride, glycine, soybean extracted liquid, polyhexamethylene biguanide, L-lactic acid and deionized water according to a certain ratio. During the production process of sanitary towels, the hydrojet is uniformly sprayed by a spraying head onto the surface layer of a sanitary towel or the hydrojet can be directly sprayed onto the sanitary towel by consumers. After the hydrojet is sprayed onto the surface layer of the sanitary towel, bacteria can be rapidly killed, the bacteria can be inhibited for a long time, and at the same time a function on eliminating the peculiar smell also can be realized. The sanitary towel hydrojet also has advantages of convenience and simplicity in operation, low application cost and the like.

The invention discloses a hygienic disinfectant moist towelette which comprises a piece of spunlace non-woven cloth and moist towelette liquid, wherein the moist towelette liquid is formed by honeysuckle water extract, benzalkonium bromide, propylene glycol, sodium methyl paraben and ultrapure water. The hygienic disinfectant moist towelette has the disinfection function, and cannot do harm to skin.

The present invention provides hemostatic and antibacterial products, including solution, dressing and bandage. The hemostatic and antibacterial products contains setose thistle herb extract in 1-30.61 wt%, zephiran chloride in 0.1-0.5 wt%, and optional local anesthetic in 1-2 wt% and/or surfactant in 0.1-0.5 wt%. The production process of the hemostatic and antibacterial products is also provided.

The present invention provides a composition for ocular topical administration for treating ocular hypertension and glaucoma, comprising latanoprost as an active ingredient, and (a) a polyol and/or sugar alcohol, (b) a nonionic surface active agent, and (c) an edetic acid compound. The composition of the present invention comprises lower amount of preservatives such as benzalkonium chloride comparative to the conventional product and therefore, can reduce incidence of the adverse side effects caused by the preservatives. In addition, the composition of the present invention can be stored stably at room temperatures for a long term.

The present invention provides an antiviral composition and system for using the same, wherein the antiviral composition includes between about 0.1 to about 0.3 wt % of antimicrobial agent such as benzalkoniumchloride, between about 0.1 to about 1 wt % of chlorinated phenol compound, such as parachlorometaxylenol, between about 0.1 to about 3 wt % of hydrogen peroxide, and at least about 60 wt % aqueous solvent.

A diflucan eye drops for treating fungal injection of eye is prepared from diflucan and propanediol through mixing, grinding, adding the water for injection, dissolving benzalkonium chloride in water for injection, mixing and stirring.

The present invention provides a Chinese medicinal washing lotion for the prevention and treatment of edeitis, which is prepared from alcohol and water extracts or pure water extracts of five kinds of Chinese medicinal herbs: Chinese globeflower, cnidium fruit, flavescent sophora root, honeysuckle flower and borneo camphor, as well as 1.5-3.8mg/100ml of benzalkonium bromide or chlorhexidine, and right amount of foaming agent within human acceptability.

The invention discloses a preparation technology of disodium adenosine triphosphate capable of reducing energy consumption. An appropriate amount of room temperature reverse osmosis water is used for dissolving adenosine to prepare an adenosine solution, the energy consumption is saved by 15% or higher, the operation is simple, and the damage to enzymes is effectively avoided. In the prior art, magnesium sulfate is selectively used as an enzymatic reaction metal ionic compound in a biochemical reaction, but the adsorption capacity of strong basic anion resin used in a subsequent technology for sulfate ions is extremely high, a great difficulty is brought for later resin regeneration treatment, and new foreign ions can be introduced; however, when magnesium chloride is used for replacing the magnesium sulfate, the adsorption capacity of strong basic anion resin for chloride ions is weaker than that of strong basic anion resin for sulfate ions, the later resin regeneration treatment is facilitated, and new foreign ions cannot be introduced. According to the preparation technology, benzalkonium bromide is used as an active agent; the benzalkonium bromide is a nontoxic and innocuous disinfectant , and the difficulty is not increased for later treatment, so that the benzalkonium bromide is a reasonable substitute; a two-stage method is adopted for vacuum drying, so that not only is the pollution avoided, but also the time is saved.

The present invention provides a preservative composition for protecting ophthalmic solutions from microbial attack comprising a combination of benzalkonium ion and An oxy-chlorite moiety, e.g. purite wherein the combined concentrations of benzalkonium ion and An oxy-chlorite moiety, e.g. purite in said composition is sufficient to provide protection against microbial attack when said composition is added to an ophthalmic solution as compared to said ophthalmic solution having the same concentration of benzalkonium ion and An oxy-chlorite moiety, e.g. purite, alone.

The invention discloses a Chinese medicine skin-disinfecting wet wipe. The Chinese medicine skin-disinfecting wet wipe is composed of a spunlace nonwoven fabric and wipe solution, wherein the wipe solution is prepared from ethylene diamine tetraacetic acid, chlorogenic acid, benzalkonium bromide, propanediol, sodium methyl parahydroxybenzoate and ultrapure water.

The invention discloses a compound dandelion wet wipe, which is composed of spunlaced nonwoven fabric and a wet wipe liquid. The wet wipe liquid comprises a honeysuckle extract, a Forsythia suspensa extract, a dandelion extract, benzalkonium bromide, propylene glycol, sodium methyl p-hydroxybenzoate, and ultra-pure water. The compound dandelion wet wipe provided by the invention has a bactericidal effect, and has no damage to the skin.

The invention provides a collective disinfectant for inhibiting viruses and pathogenic bacteria. The collective disinfectant is prepared from a bactericide, fullerene, nano tourmaline, a Chinese herbal medicine extract, fresh bamboo juice, phosphorylated titanium dioxide and water. The invention also provides a preparation method of the collective disinfectant for inhibiting viruses and pathogenicbacteria, which comprises the following steps: adding the bactericide, fullerene and Chinese herbal medicine extract into water, and uniformly stirring to obtain a mixed solution A; uniformly mixingnano tourmaline, phosphorylated titanium dioxide and fresh bamboo juice to obtain a mixed solution B; and adding the mixed solution B into the mixed solution A in a stirring state, and fully mixing toobtain a collective disinfectant product. According to the invention, benzalkonium chloride is used as a main body bactericide, and a plurality of plant traditional Chinese medicinal material extracts, health-care functional components and a plurality of auxiliary materials for enhancing the functions of killing viruses and harmful bacteria are added.

The invention discloses a fiber oil agent for reducing frictional static electricity. The fiber oil agent per kilogram comprises the following components in part by weight, 50.0-120.0g of fatty alcohol-polyoxyethylene ether, 100.0-180.0g of benzalkonium bromide, 50.0-160.0g of alkylphenol ethoxylates, 40.0-70.0g of polyoxyethylene alkyl phosphate potassium, 50.0-70.0g of fatty acid triglyceride, 20.0-40.0g of butyl cellosolve, 10.0-25.0g of fatty acid sorbitan, 5.0-10.0g of imidazoline and the rest mineral oil.

The invention discloses a compound asparticitin gutta and making method, which comprises the following parts: aspartic acid, vitamin B6, glycyrrhizin dipotassium, naphazoline hydrochloride, neostigmine methylsulfate, maleic chlorobenzenenamin, polysorbate 80, sodium chloride, menthol, benzachloridamine, sodium hydroxide solution and injecting water. The invention paves basis for scaling manufacturing of the compound asparticitin gutta further, which improves the productivity with stable content of maleic chlorobenzenenamin.

The invention relates to a preparation method of a gynecological lotion. The preparation method comprises the following steps of: (1) adding 1-3% of sodium bicarbonate, 1.5-2.0% of metronidazole and 1.0-2.0% of benzalkonium bromide into an appropriate amount of sterile water and uniformly mixing; (2) adding 3-10% of propanetriol and uniformly stirring; and (3) adding water to make up to 100% and uniformly stirring to obtain a finished product. The cure rate of the gynecological lotion prepared by the preparation method disclosed by the invention against fungal vaginitis achieves 95%. The gynecological lotion also has the efficacy in different degrees against other gynecological diseases, such as trichomonal vaginitis, cervical erosion and the like.